Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
91
天
Treatment attrition and outcomes of myeloma patients in Finland: a real-world study
作者
Mervi Putkonen; Katja Närhi; Johanna Vikkula; Riikka Mattila; Marika Waltari; Jonna Eeva; Anu Partanen展开收起
作者单位
1. Hematology and Stem Cell Transplant Unit, Wellbeing Services County of Southwest Finland, Turku University Hospital, Turku, Finland; 2. Johnson & Johnson, Espoo, Finland; 3. Medaffcon Oy, Espoo, Finland; 4. Department of Medicine, Wellbeing Services County of Pirkanmaa, Tampere University Hospital, Tampere, Finland; 5. Department of Medicine, Wellbeing Services County of North Savo, Kuopio University Hospital, Kuopio, Finland展开收起
81
天
Co-mutation patterns and survival associations in lung cancer: a comparative analysis of Swedish and global cohorts
作者
Nicholas Karlowatz; Linda Köhn; Cedric Patthey; Jonas Nilsson; Mikael Johansson展开收起
作者单位
1. Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden; 2. Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden展开收起
77
天
FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland
作者
Aija Knuuttila; Monica H. Ekblom; Lalli O. Nurmi; Anna Bonin; Eija K. Heikkilä; Maria Silvoniemi展开收起
作者单位
1. Department of Pulmonary Medicine, Heart and Lung Center, and Cancer Center, Helsinki University Central Hospital, Helsinki, Finland; 2. Johnson & Johnson, Espoo, Finland; 3. Nordic Healthcare Group, Espoo, Finland; 4. Johnson & Johnson, Solna, Sweden; 5. Department of Respiratory Medicine, Turku University Central Hospital, Turku, Finland展开收起
84
天
Disparities in initiating standard first-line cancer treatment and survival for patients with an immigrant background: a Danish register-based cohort study
作者
Emma N. Ishøy; Maria Kristiansen; Ismail Gögenur; Erik Jakobsen; Lars Lund; Fie Stegenborg; Susanne Rosthøj; Mia K. Grand; Pernille Bidstrup; Morten Sodemann; Susanne O. Dalton展开收起
作者单位
1. Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; 2. Danish Research Center for Equality in Cancer, Zealand University Hospital, Næstved, Denmark; 3. Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 4. Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark; 5. Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark; 6. Department of Urology, Odense University Hospital, Odense, Denmark; 7. Statistics and Data Analysis, Danish Cancer Institute, Copenhagen, Denmark; 8. Psychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; 9. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark; 10. Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark展开收起
66
天
Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature
作者
Panagiotis Filis; Magnus Lindskog; Philip Curman; Natalia Kuzmina; Åsa Krantz; Katerina Chatzidionysiou; Fernanda Costa Svedman; Ioannis Zerdes展开收起
作者单位
1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Department of Pelvic Cancer, Genitourinary Oncology, Karolinska University Hospital, Stockholm, Sweden; 3. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; 4. Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; 5. Dermatology and Venereology Section, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 6. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 7. Department of Rheumatology, Theme Inflammation and Geriatrics, Karolinska University Hospital, Stockholm, Sweden; 8. Rheumatology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; 9. Theme Cancer, Karolinska University Hospital, Stockholm, Sweden展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天